Safety and efficacy of apixaban versus warfarin in patients with end‐stage renal disease: Meta‐analysis期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Safety and efficacy of apixaban versus warfarin in patients with end‐stage renal disease: Meta‐analysis

Authors:	Ronpichai Chokesuwattanaskul MD Charat Thongprayoon MD Tanyanan Tanawuttiwat MD Wisit Kaewput MD Pavida Pachariyanon MD Wisit Cheungpasitporn MD

Affiliation:	1. Division of Cardiology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand;2. Department of Internal Medicine, Bassett Medical Center, Cooperstown, NY, USA;3. Division of Cardiology, Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA;4. Department of Military and Community Medicine, Phramongkutklao College of Medicine, Bangkok, Thailand;5. Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA;6. Division of Nephrology, Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA

Abstract:

Keywords:	apixaban atrial fibrillation bleeding complication meta‐analysis thromboembolic events vitamin K antagonist warfarin